Abstract
In the present paper a modern sights to strategy of treatment of brain function’s disturbances of ischemic genesis in angioneurological pathology have been looked. Based on this point of view, the requirements to choice of optimal pharmacological tool of this strategy have been analyzed. A main attention paid to mechanisms of action and peculiarities of clinical use of drugs – calcium channels blockers and in particularly to nimodipine (Nemotan) - drug with unique pharmacological and clinical properties that make possible to realize the strategy of neuro-, gero- and angioprotection’s pharmacotherapy in cerebrovascular pathology. A clinico-pharmacological effects of nimodipine (Nemotan) and possibilities of its use in clinical practice have been looked in detail.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
